Your browser doesn't support javascript.
loading
A Novel Microtubule Inhibitor Overcomes Multidrug Resistance in Tumors.
Ning, Nannan; Yu, Yamei; Wu, Min; Zhang, Ruihong; Zhang, Ting; Zhu, Changjun; Huang, Lei; Yun, Cai-Hong; Benes, Cyril H; Zhang, Jianming; Deng, Xianming; Chen, Qiang; Ren, Ruibao.
Afiliação
  • Ning N; State Key Laboratory for Medical Genomics, Shanghai Institute of Hematology, Collaborative Innovation Center of Hematology, Collaborative Innovation Center of System Biology, Ruijin Hospital, School of Life Sciences and Biotechnology and School of Medicine, Shanghai Jiao Tong University, Shanghai, C
  • Yu Y; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Collaborative Innovation Center for Biotherapy, Sichuan University, Chengdu, China.
  • Wu M; State Key Laboratory for Medical Genomics, Shanghai Institute of Hematology, Collaborative Innovation Center of Hematology, Collaborative Innovation Center of System Biology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang R; State Key Laboratory for Medical Genomics, Shanghai Institute of Hematology, Collaborative Innovation Center of Hematology, Collaborative Innovation Center of System Biology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang T; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, China.
  • Zhu C; Tianjin Key Laboratory of Animal and Plant Resistance, College of Life Sciences, Tianjin Normal University, Tianjin, China.
  • Huang L; Key Laboratory of Cell Differentiation and Apoptosis of The Chinese Ministry of Education, Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Yun CH; Institute of Systems Biomedicine, Department of Biophysics, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
  • Benes CH; Massachusetts General Hospital, Charlestown, Massachusetts.
  • Zhang J; State Key Laboratory for Medical Genomics, Shanghai Institute of Hematology, Collaborative Innovation Center of Hematology, Collaborative Innovation Center of System Biology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Deng X; Massachusetts General Hospital, Charlestown, Massachusetts.
  • Chen Q; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, China. ren@brandeis.edu qiang_chen@scu.edu.cn xmdeng@xmu.edu.cn.
  • Ren R; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Collaborative Innovation Center for Biotherapy, Sichuan University, Chengdu, China. ren@brandeis.edu qiang_chen@scu.edu.cn xmdeng@xmu.edu.cn.
Cancer Res ; 78(20): 5949-5957, 2018 10 15.
Article em En | MEDLINE | ID: mdl-30135190
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência a Múltiplos Medicamentos / Resistencia a Medicamentos Antineoplásicos / Moduladores de Tubulina / Microtúbulos Limite: Animals / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência a Múltiplos Medicamentos / Resistencia a Medicamentos Antineoplásicos / Moduladores de Tubulina / Microtúbulos Limite: Animals / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos